Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 5
2014 4
2016 2
2017 2
2018 2
2019 2
2020 5
2021 16
2022 14
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.
Landi D, Bartolomeo S, Bovis F, Amato MP, Bonavita S, Borriello G, Buccafusca M, Bucello S, Cavalla P, Cellerino M, Centonze D, Cocco E, Conte A, Cortese A, D'Amico E, Di Filippo M, Docimo R, Fantozzi R, Ferraro E, Filippi M, Foschi M, Gallo A, Granella F, Ianniello A, Lanzillo R, Lorefice L, Lucchini M, Lus G, Mataluni G, Mirabella M, Moiola L, Napoli F, Nicoletti CG, Patti F, Ragonese P, Realmuto S, Schirò G, Signoriello E, Sinisi L, Stromillo ML, Tomassini V, Vecchio D, Sormani MP, Marfia GA. Landi D, et al. Among authors: nicoletti cg. Mult Scler. 2024 Oct;30(11-12):1503-1513. doi: 10.1177/13524585241274600. Epub 2024 Sep 12. Mult Scler. 2024. PMID: 39263885
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
Landi D, Bovis F, Grimaldi A, Annovazzi PO, Bertolotto A, Bianchi A, Borriello G, Brescia Morra V, Bucello S, Buscarinu MC, Caleri F, Capobianco M, Capra R, Cellerino M, Centonze D, Cerqua R, Chisari CG, Clerico M, Cocco E, Cola G, Cordioli C, Curti E, d'Ambrosio A, D'Amico E, De Luca G, Di Filippo M, Di Lemme S, Fantozzi R, Ferraro D, Ferraro E, Gallo A, Gasperini C, Granella F, Inglese M, Lanzillo R, Lorefice L, Lus G, Malucchi S, Margoni M, Mataluni G, Mirabella M, Moiola L, Nicoletti CG, Nociti V, Patti F, Pinardi F, Portaccio E, Pozzilli C, Ragonese P, Rasia S, Salemi G, Signoriello E, Vitetta F, Totaro R, Sormani MP, Amato MP, Marfia GA. Landi D, et al. Among authors: nicoletti cg. J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 36180219
Frailty and relapse activity in multiple sclerosis: A longitudinal observation.
Baione V, Canevelli M, Belvisi D, Buscarinu MC, Bellucci G, Fantozzi R, Nicoletti CG, Malatuni G, Cortese A, De Giglio L, Tartaglia M, Ferrazzano G, Malimpensa L, Leodori G, Bruno G, Ferraro E, Marfia GA, Centonze D, Salvetti M, Conte A. Baione V, et al. Among authors: nicoletti cg. Mult Scler Relat Disord. 2023 Apr;72:104603. doi: 10.1016/j.msard.2023.104603. Epub 2023 Mar 5. Mult Scler Relat Disord. 2023. PMID: 36905818
What happens after fingolimod discontinuation? A multicentre real-life experience.
Landi D, Signori A, Cellerino M, Fenu G, Nicoletti CG, Ponzano M, Mancuso E, Fronza M, Ricchiuto ME, Boffa G, Inglese M, Marfia GA, Cocco E, Frau J. Landi D, et al. Among authors: nicoletti cg. J Neurol. 2022 Feb;269(2):796-804. doi: 10.1007/s00415-021-10658-8. Epub 2021 Jun 16. J Neurol. 2022. PMID: 34136943
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Landi D, Cola G, Mantero V, Balgera R, Moiola L, Nozzolillo A, Dattola V, Sinisi L, Fantozzi R, Di Lemme S, Centonze D, Mataluni G, Nicoletti CG, Marfia GA. Landi D, et al. Among authors: nicoletti cg. Mult Scler Relat Disord. 2022 Jan;57:103345. doi: 10.1016/j.msard.2021.103345. Epub 2021 Oct 24. Mult Scler Relat Disord. 2022. PMID: 35158454 Free PMC article.
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis.
Stampanoni Bassi M, Buttari F, Nicoletti CG, Mori F, Gilio L, Simonelli I, De Paolis N, Marfia GA, Furlan R, Finardi A, Centonze D, Iezzi E. Stampanoni Bassi M, et al. Among authors: nicoletti cg. Int J Mol Sci. 2020 Sep 23;21(19):6982. doi: 10.3390/ijms21196982. Int J Mol Sci. 2020. PMID: 32977401 Free PMC article. Clinical Trial.
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis.
Proietti F, Landi D, Ponzano M, Cola G, Di Mauro G, Mataluni G, Nicoletti CG, Curcio G, Marfia GA. Proietti F, et al. Among authors: nicoletti cg. Neurol Sci. 2023 Mar;44(3):803-808. doi: 10.1007/s10072-022-06559-x. Epub 2022 Dec 26. Neurol Sci. 2023. PMID: 36567409 Free PMC article.
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.
Bisecco A, Matrone F, Capobianco M, De Luca G, Filippi M, Granella F, Lus G, Marfia GA, Mirabella M, Patti F, Trojano M, Mascolo A, Copetti M, Tedeschi G, Gallo A; OCREVID study group on behalf of the Italian MS Register. Bisecco A, et al. J Neurol. 2024 Feb;271(2):699-710. doi: 10.1007/s00415-023-12084-4. Epub 2023 Nov 20. J Neurol. 2024. PMID: 37982852 Free PMC article.
47 results